These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28649551)

  • 1. Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.
    Sato Y; Fujiwara M; Kobayashi H; Yoshitake M; Hashimoto K; Oto Y; Ida H
    Mol Genet Metab Rep; 2015 Dec; 5():94-97. PubMed ID: 28649551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.
    Sugiura K; Kubo T; Ochi Y; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Mol Genet Metab Rep; 2020 Dec; 25():100662. PubMed ID: 33101981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.
    Gonzalez EA; Visioli F; Pasqualim G; de Souza CFM; Marinho DR; Giugliani R; Matte U; Baldo G
    Clin Exp Ophthalmol; 2020 Apr; 48(3):334-342. PubMed ID: 31925897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valve surgery in a mucopolysaccharidosis type I patient: early prosthetic valve endocarditis.
    Rocha RV; Alvarez RJ; Bermudez CA
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):448-9. PubMed ID: 21820914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.
    Thomas JA; Jacobs S; Kierstein J; Van Hove J
    J Inherit Metab Dis; 2006 Dec; 29(6):762. PubMed ID: 17089217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.
    Schroeder L; Orchard P; Whitley CB; Berry JM; Tolar J; Miller W; Braunlin EA
    JIMD Rep; 2013; 10():87-94. PubMed ID: 23430808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.
    Braunlin EA; Harmatz PR; Scarpa M; Furlanetto B; Kampmann C; Loehr JP; Ponder KP; Roberts WC; Rosenfeld HM; Giugliani R
    J Inherit Metab Dis; 2011 Dec; 34(6):1183-97. PubMed ID: 21744090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.
    Kobayashi H; Ariga M; Sato Y; Fujiwara M; Fukasawa N; Fukuda T; Takahashi H; Ikegami M; Kosuga M; Okuyama T; Eto Y; Ida H
    JIMD Rep; 2018; 41():101-107. PubMed ID: 29705972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report.
    Tatapudi R; Gunashekhar M; Raju PS
    Contemp Clin Dent; 2011 Jan; 2(1):66-8. PubMed ID: 22114460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.
    Brazier A; Hasan R; Jenkins P; Hoschtitzky A
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26546621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.
    Illsinger S; Lücke T; Hartmann H; Mengel E; Müller-Forell W; Donnerstag F; Das AM
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S321-5. PubMed ID: 19894140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Manifestations of Hurler-Scheie Syndrome: Recurrence of Host Disease in the Corneal Transplant.
    Kölkedi Z; Csutak A; Szalai E
    Mol Syndromol; 2023 Feb; 14(1):44-50. PubMed ID: 36777710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ullrich-Scheie syndrome).
    Fischer TA; Lehr HA; Nixdorff U; Meyer J
    Heart; 1999 Jan; 81(1):97-9. PubMed ID: 10220555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laronidase treatment of mucopolysaccharidosis I.
    Wraith EJ; Hopwood JJ; Fuller M; Meikle PJ; Brooks DA
    BioDrugs; 2005; 19(1):1-7. PubMed ID: 15691212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laronidase for the treatment of mucopolysaccharidosis type I.
    Clarke LA
    Expert Rev Endocrinol Metab; 2011 Nov; 6(6):755-768. PubMed ID: 30780865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.